Kindred Biosciences reported $108.87M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adma Biologics ADMA:US $ 238.64M 5.83M
Bayer BAYN:GR € 116549M 2122M
Biocryst Pharmaceuticals BCRX:US $ 265.76M 11.52M
Dynavax Technologies DVAX:US $ 919.71M 271.8M
Eli Lilly And LLY:US $ 48187M 378M
Idexx Laboratories IDXX:US $ 2385.74M 26.4M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Kindred Biosciences KIN:US $ 108.87M 1.11M
Minerva Neurosciences NERV:US $ 97.56M 7.77M
Novavax NVAX:US $ 2565.94M 183.65M
Phibro Animal Health PAHC:US $ 836.04M 5.28M
Zoetis ZTS:US $ 13705M 364M